Free Republic

Pfizer announced on Thursday that its COVID vaccine booster shot could further protect individuals from "all currently known variants" of COVID-19 — including the highly transmittable Delta variant. The booster shot is currently undergoing trials, the company said, and has shown "encouraging clinical trial data in a small number of participants in our study." Pfizer said that the initial two doses that patients received have elicited "strong immune responses" against the Delta variant and that current studies are focused on whether the booster shot will increase that response even further. Trial data has shown that when given six months after...

This is 8 minutes from a Immunologist Dr Vyram Bridle that is pro vaccine. What he states here is from peer reviewed in well known scietific publiccations talkinga bout this now. This is probably why they are turning on Fauci, and they do not want to get into trouble?In short they made a big mistake with assumptions of where the mRNA goes after vaccination? Is it safe to assume it stays only stays in the shoulder muscle? The short answer is no. The spike protein gets into the blood and circulates through the blood over several days post vaccination. It...

This doctor talks about Absolute Risk Reduction (ARR) and Relative Risk Reduction (RRD) of the Covid "vaccines." You will be shocked. We are living through a perfect example of lying with statistics. Interesting to note that to prevent just 1 Covid-19 case 256 individuals must get the vaccine; the other 255 individuals derive no benefit, but are subject to vaccine adverse effects, whatever they may be. Dr. Ron Brown of Waterloo University talks about his Cambridge and Medicina Paper. We discuss relative risk reduction and absolute risk reduction measures in the evaluation of clinical trial data. Dr. Ron Brown discusses...

TUCSON, Ariz., April 5, 2021 /PRNewswire/ -- More than a dozen countries worldwide temporarily stopped administering the Oxford-AstraZeneca COVID vaccine, notes the Association of American Physicians and Surgeons (AAPS), because of deaths from blood clotting disorders, with either clots or excessive bleeding. Some patients experienced the extremely rare event of clots in the veins that drain blood from the brain (venous sinus thrombosis). Most countries resumed use after a short pause, when the European Medicines Agency (EMA) said the shot isn't associated with an increase in the overall risk of developing blood clots, and the benefits of using the vaccine...